Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Lynett

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Gastro Hep Advances|April 9, 2026
Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Reintroduction in Clinical Practice: Surveying the Gaps and OpportunitiesKate Pelletier, Megan Villarreal, Rowan Klar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 18, 2023
Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic EsophagitisJoy W Chang, Kara Kliewer, Emily Haller, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2026
A Randomized Trial of Rifaximin vs Low FODMAP Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel SyndromeAllen Lee, Krishna Rao, Prashant Singh, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Gastro Hep Advances|April 9, 2026
Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Reintroduction in Clinical Practice: Surveying the Gaps and OpportunitiesKate Pelletier, Megan Villarreal, Rowan Klar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 18, 2023
Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic EsophagitisJoy W Chang, Kara Kliewer, Emily Haller, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2026
A Randomized Trial of Rifaximin vs Low FODMAP Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel SyndromeAllen Lee, Krishna Rao, Prashant Singh, et al.
Pageof 1